In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Modification Regulation as regards botanical species containing hydroxyanthracene derivatives

Modification Regulation as regards botanical species containing hydroxyanthracene derivatives

by In2Pharma | Mar 29, 2021 | News

Europe Commission Regulation (EU) 2021/468 of 18 March 2021 amends Annex III to Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and of certain other substances to food as regards botanical species containing hydroxyanthracene...

Recent Posts

  • Medical devices – turnover declaration
  • Update instructions for distribution of DHPC in Luxembourg
  • Diploma for the Responsible Person for Information and Publicity (RIP)
  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België